We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$110B
AUM Growth
+$10.8B
Cap. Flow
+$4.52B
Cap. Flow %
4.11%
Top 10 Hldgs %
23.63%
Holding
4,320
New
332
Increased
2,194
Reduced
1,423
Closed
241

Sector Composition

Rank Sector Weight
1 Technology 14.49%
2 Financials 8.91%
3 Healthcare 8.14%
4 Industrials 6.57%
5 Consumer Discretionary 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GPP
3551
DELISTED
Green Plains Partners LP
GPP
$247K ﹤0.01%
19,295
-4,112
-18% -$50.3K
JPN
3552
DELISTED
Xtrackers Japan JPX-Nikkei 400 Equity ETF
JPN
$247K ﹤0.01%
+7,582
New +$251K
INBK icon
3553
First Internet Bancorp
INBK
$259M
$246K ﹤0.01%
+7,934
New +$269K
SDIV icon
3554
Global X SuperDividend ETF
SDIV
$1.21B
$246K ﹤0.01%
5,791
+351
+6% +$15K
EGHT icon
3555
8x8 Inc
EGHT
$315M
$244K ﹤0.01%
8,772
+22
+0.3% +$624
HRZN icon
3556
Horizon Technology Finance
HRZN
$326M
$244K ﹤0.01%
14,102
-370
-3% -$6.11K
PHT
3557
DELISTED
Pioneer High Income Fund
PHT
$243K ﹤0.01%
25,019
AUD
3558
DELISTED
Audacy, Inc.
AUD
$243K ﹤0.01%
56,329
-250
-0.4% -$1.15K
ARCH
3559
DELISTED
Arch Resources, Inc.
ARCH
$243K ﹤0.01%
+4,269
New +$223K
GOOD
3560
Gladstone Commercial Corp
GOOD
$624M
$242K ﹤0.01%
10,726
-4,267
-28% -$91.2K
WRAP icon
3561
Wrap Technologies
WRAP
$105M
$242K ﹤0.01%
30,850
+1,855
+6% +$12.7K
CIG icon
3562
CEMIG Preferred Shares
CIG
$5.75B
$241K ﹤0.01%
171,381
-14,262
-8% -$19.7K
HIMX
3563
Himax Technologies
HIMX
$2.62B
$241K ﹤0.01%
14,467
+1,868
+15% +$24.7K
FTDR icon
3564
Frontdoor
FTDR
$5.87B
$240K ﹤0.01%
4,810
-23,646
-83% -$1.25M
MIRM icon
3565
Mirum Pharmaceuticals
MIRM
$6.09B
$240K ﹤0.01%
13,874
-20,000
-59% -$358K
QSI icon
3566
Quantum-Si Incorporated
QSI
$182M
$239K ﹤0.01%
19,494
-151,791
-89% -$1.59M
SSO icon
3567
ProShares Ultra S&P500
SSO
$8.38B
$239K ﹤0.01%
+8,000
New +$226K
ALX
3568
Alexander's
ALX
$1.4B
$238K ﹤0.01%
+889
New +$246K
GENZ
3569
VanEck Digital Native Economy ETF
GENZ
$17.8M
$237K ﹤0.01%
4,459
+217
+5% +$11.8K
TCRT icon
3570
Alaunos Therapeutics
TCRT
$4.81M
$237K ﹤0.01%
597
-44
-7% -$20.5K
EVX icon
3571
VanEck Environmental Services ETF
EVX
$102M
$235K ﹤0.01%
+8,315
New +$233K
FCF icon
3572
First Commonwealth Financial
FCF
$2.18B
$235K ﹤0.01%
16,718
+1,360
+9% +$20K
SFIX
3573
Stitch Fix
SFIX
$503M
$235K ﹤0.01%
3,903
-14,532
-79% -$744K
CLNE icon
3574
Clean Energy Fuels
CLNE
$388M
$234K ﹤0.01%
23,027
-60,580
-72% -$625K
CVAC
3575
DELISTED
CureVac
CVAC
$234K ﹤0.01%
+3,183
New +$318K

Similar funds

Raymond James & Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Raymond James & Associates held 4,320 positions worth $110B, up 11% from $99.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates deployed $4.52B of net new capital in Q2 2021, opening 332 new positions and adding to 2,194 existing holdings. Its largest new stake was Just Eat Takeaway.com N.V. American Depositary Shares: 583,879 shares worth $10.7M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $175M trimmed.

  • Raymond James & Associates's largest Q2 2021 buy was Just Eat Takeaway.com N.V. American Depositary Shares: 583,879 shares worth $10.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2021, an estimated $290M increase.
  • Raymond James & Associates's biggest Q2 2021 reduction was Amgen, cutting an estimated $175M.
  • Raymond James & Associates fully exited FLIR Systems, Inc. (DE) Common Stock in Q2 2021, selling an estimated $19.1M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $110B portfolio in Q2 2021.
  • Raymond James & Associates opened 332 new positions and closed 241 in Q2 2021.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $110B.

Based on Raymond James & Associates's 13F filing for Q2 2021, filed 11 Aug 2021.